Evidence map›Paper›PMID 27919888›Full record

ArticleAntimicrobial agents and chemotherapy2017

Identification of a Novel Lincomycin Resistance Mutation Associated with Activation of Antibiotic Production in Streptomyces coelicolor A3(2).

Guojun Wang, Masumi Izawa, Xiaoge Yang, Dongbo Xu, Yukinori Tanaka, Kozo Ochi

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Two-Component Systems ofInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Guojun WangHarbor Branch Oceanographic Institute, Florida Atlantic University, Fort Pierce, Florida, USA.
Masumi IzawaDepartment of Life Sciences, Hiroshima Institute of Technology, Hiroshima, Japan.
Xiaoge YangHarbor Branch Oceanographic Institute, Florida Atlantic University, Fort Pierce, Florida, USA.
Dongbo XuHarbor Branch Oceanographic Institute, Florida Atlantic University, Fort Pierce, Florida, USA.
Yukinori TanakaDepartment of Life Sciences, Hiroshima Institute of Technology, Hiroshima, Japan.
Kozo OchiDepartment of Life Sciences, Hiroshima Institute of Technology, Hiroshima, Japan k.ochi.bz@it-hiroshima.ac.jp.
Harbor Branch Oceanographic Institute · USHiroshima Institute of Technology · JP

Funding

Identifying the biosynthesis of a potent cytotoxic agent Lasonolide AR21CA209189 · NCI · FLORIDA ATLANTIC UNIVERSITY · PI WANG, GUOJUN · 2016 to 2017
$384k
NCI NIH HHS R21 CA209189
6 · The paper itself

Abstract

Comparative genome sequencing analysis of a lincomycin-resistant strain of Streptomyces coelicolor A3(2) and the wild-type strain identified a novel mutation conferring a high level of lincomycin resistance. Surprisingly, the new mutation was an in-frame DNA deletion in the genes SCO4597 and SCO4598, resulting in formation of the hybrid gene linR. SCO4597 and SCO4598 encode two histidine kinases, which together with SCO4596, encoding a response regulator, constitute a unique two-component system. Sequence analysis indicated that these three genes and their arrangement patterns are ubiquitous among all Streptomyces genomes sequenced to date, suggesting these genes play important regulatory roles. Gene replacement showed that this mutation was responsible for the high level of lincomycin resistance, the overproduction of the antibiotic actinorhodin, and the enhanced morphological differentiation of this strain. Moreover, heterologous expression of the hybrid gene linR in Escherichia coli conferred resistance to lincomycin in this organism. Introduction of the hybrid gene linR in various Streptomyces strains by gene engineering technology may widely activate and/or enhance antibiotic production.

Indexed as

Anti-Bacterial AgentsGene Expression Regulation, BacterialLincomycinMutationStreptomyces coelicolorAnti-Bacterial AgentsLincomycinantibiotic productioncryptic geneslincomycin resistanceStreptomyces coelicolorStreptomyces lividanstwo-component system

Identifiers

PMID27919888
PMCPMC5278706
OpenAlexW2560288261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.